These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6389371)

  • 1. Production and characterization of antisera against guinea pig macrophage activating factor.
    Peck R; Talmadge K; Polak L
    Int Arch Allergy Appl Immunol; 1984; 75(4):361-7. PubMed ID: 6389371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lymphokines in regulation of macrophage differentiation.
    Onozaki K; Akagawa KS; Haga S; Miura K; Hashimoto T; Tokunaga T
    Cell Immunol; 1983 Feb; 76(1):129-36. PubMed ID: 6339080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of an antibody against guinea pig MIF. III. Biological activity of MIF recovered from immunoadsorbent column chromatography.
    Onozaki K; Haga S; Ichikawa M; Homma Y; Miura K; Hashimoto T
    Cell Immunol; 1981 Jun; 61(1):165-75. PubMed ID: 7020954
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of an antibody against guinea pig MIF. I. Specificity of the anti-MIF antibody.
    Onozaki K; Haga S; Miura K; Ichikawa M; Hashimoto T
    Cell Immunol; 1979 Dec; 48(2):258-66. PubMed ID: 389441
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of an antibody against guinea pig MIF. II. Analysis of the antibody-reacting material using radiolabeled lymphokines.
    Onozaki K; Haga S; Miura K; Homma Y; Hashimoto T
    Cell Immunol; 1980 Oct; 55(2):465-75. PubMed ID: 7000379
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
    Cameron DJ
    J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lymphokine antibody. II. Specificity of biological activity.
    Kuratsuji T; Yoshida T; Cohen S
    J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to guinea pig lymphokines. IV. Suppression of the mixed leukocyte culture reaction by anti-lymphokine globulin.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Nov; 117(5 Pt.2):1824-31. PubMed ID: 136471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparsion of the properties of two antigen-induced guinea pig lymphokines.
    Ashworth LA; Eckersley BJ; Ford WH
    Int Arch Allergy Appl Immunol; 1975; 48(1):143-55. PubMed ID: 46849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to guinea pig lymphokines. VII. Reactivity with products of lymphoid and nonlymphoid cells.
    Sorg C; Geczy CL
    J Immunol; 1978 Sep; 121(3):1199-205. PubMed ID: 99476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activating factor is not identical with immune interferon or a factor inducing differentiation of mouse myeloid leukemic cells.
    Yamamoto Y; Tomida M; Hozumi M
    Gan; 1982 Aug; 73(4):557-64. PubMed ID: 6818089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and in vivo effect of antibodies against guinea pig lymphokines.
    Geczy CL; Friedrich W; de Weck AL
    Cell Immunol; 1975 Sep; 19(1):65-77. PubMed ID: 1102116
    [No Abstract]   [Full Text] [Related]  

  • 19. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.